Amy Stoll-D’Astice is an accomplished research professional in Clinical Operations with 20 years of experience in leading clinical trial operations, portfolio and site management, and strategic clinical development within mostly Oncology studies and some rare disease studies. She has worked in the Oncology therapeutic area for a majority of her career, designing clinical trials in the Phase 1 and Phase 2 space.
She earned a Bachelors Degree in Biology at Arizona State University, and a Masters of Science Degree, specializing in Toxicology, at Colorado State University.
Early in her Clinical Research career, she worked at the Translational Genomics Research Institute (TGen), which launched her career in Oncology research. Since then, she has been devoted to working on novel and innovative therapies for cancer patients, to bring more effective treatment strategies to the clinic.
Amy is skilled in fostering team development and driving the execution of cutting-edge clinical protocols. She is poised to add to the wealth of knowledge and innovative strategies at HonorHealth Research Institute to ensure excellent project delivery and operational excellence.
She has lived in the Phoenix area for over 30 years where she raised her family.